원료의약품(API) 시장 : 제품 유형별, 분자 유형별, 제형별, 용도별, 지역별

The global active pharmaceutical ingredients market is estimated to be valued at US$ 235 Billion in 2023 and is expected to exhibit a CAGR of 6.8% during the forecast period (2023-2030).

Global Active Pharmaceutical Ingredients Market Share (%), By Product Type, 2023

Active pharmaceutical ingredients (APIs) and excipients are the two most important components in the production of a medication. API is the raw material that is used in manufacturing medications, whereas an excipient is a substance that functions as a medium to help the body absorb the drug, such as lactose or mineral oil in a tablet. Active pharmaceutical ingredients are produced by using highly technological industrial processes, both during the research and development and commercial production phases. Such compounds are developed to provide pharmacological activity or other direct impacts on disease diagnosis, cure, mitigation, therapy, or prevention, or to change the structure and function of the body. The growth of the active pharmaceutical ingredients (API) market can be attributed to certain factors, such as increasing funding initiatives by the government across different regions. For instance, in May 2020, the U.S. Department of Health and Human Services (HHS) announced that it will provide funding of US$ 354 million to Phlow Corporation, a pharmaceutical company, under a four-year contract to produce the active pharmaceutical ingredientss (APIs) needed for medications to treat patients with COVID-19 and related illnesses.

Market Dynamics

The rising U.S. Food and Drug Administration (FDA) approvals for drugs by pharmaceutical companies are further expected to boost the global active pharmaceutical ingredients (API) market growth during the forecast period. For instance, in December 2020, Eily Lilly, an American pharmaceutical company received U.S FDA clearance for several medicines, including increased dosages of its Trulicity therapy for the treatment of type 2 diabetes, Cyramza for the treatment of metastatic Estimated Glomerular Filteration Rate (EGFR)-mutated non-small cell lung cancer, and tauvid for individuals diagnosed with Alzheimer's disease.

Key features of the study:

• This report provides an in-depth analysis of the global active pharmaceutical ingredients (API) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global active pharmaceutical ingredients (API) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies.
• Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Dr. Reddy's Laboratories Ltd., Novartis AG, Mylan N.V., Amneal Pharmaceuticals LLC, Lonza Group, Lupin Limited, Fresenius Kabi, Hikma Pharmaceuticals, Cipla Limited, Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Endo International plc, Aurobindo Pharma Limited, Apotex Inc, Taro Pharmaceutical Industries Ltd, Stada Arzneimittel AG, Krka Pharmaceuticals, CordenPharma International, Evonik Industries AG, and Biological E. Limited.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global active pharmaceutical ingredients (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global active pharmaceutical ingredients (API) market.

Active Pharmaceutical Ingredients (API) Market Detailed Segmentation:

• By Product Type:
  • Low Potent APIs
  • High Potent APIs
• By Molecular Type:
  • Small Molecules
  • Large Molecules
• By Formulation:
  • Oral
  • Topical
  • Injectables
  • Drops
• By Application:
  • Diabetes
  • Oncology
  • Cardiovascular
  • CNS
  • Analgesics
  • Ophthalmic
  • Respiratory
  • Dermatology
  • Others
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Teva Pharmaceutical Industries Ltd
  • Pfizer, Inc.
  • Reddy's Laboratories Ltd
  • Novartis AG
  • Mylan N.V.
  • Amneal Pharmaceuticals LLC
  • Lonza Group
  • Lupin Limited
  • Fresenius Kabi
  • Hikma Pharmaceuticals
  • Cipla Limited
  • Glenmark Pharmaceuticals Limited
  • Sun Pharmaceutical Industries Ltd
  • Reddy's Laboratories Ltd
  • Endo International plc
  • Aurobindo Pharma Limited
  • Apotex Inc.
  • Taro Pharmaceutical Industries Ltd
  • Stada Arzneimittel AG
  • Krka Pharmaceuticals
  • CordenPharma International
  • Evonik Industries AG
  • Biological E. Limited

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Molecular Type
  • Market Snippet, By Formulation
  • Market Snippet, By Application
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunity
• Impact Analysis
• Regulatory Scenario
• Market Trends
• API Patent Expiration
• Production Capability Analysis
• Mergers, Acquisitions and Collaboration Scenario
• Key Developments
• PEST Analysis
• Investments & Funding
• Production and Consumption Analysis

4. Global Active Pharmaceutical Ingredients (API) Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Active Pharmaceutical Ingredients (API) Market, By Product Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Low Potent APIs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• High Potent APIs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Active Pharmaceutical Ingredients (API) Market, By Molecular Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Small Molecules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Large Molecules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Injectables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Drops
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Cardiovascular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• CNS
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
• Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
• Ophthalmic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
• Respiratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
• Dermatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

9. Global Active Pharmaceutical Ingredients (API) Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 -2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018-2030, (US$ Bn)
  • Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Company Profiles
  • Teva Pharmaceutical Industries Ltd
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Strategies
  • Pfizer, Inc.
  • Dr. Reddy's Laboratories Ltd
  • Novartis AG
  • Mylan N.V.
  • Amneal Pharmaceuticals LLC
  • Lonza Group
  • Lupin Limited
  • Fresenius Kabi
  • Hikma Pharmaceuticals
  • Cipla Limited
  • Glenmark Pharmaceuticals Limited
  • Sun Pharmaceutical Industries Ltd
  • Endo International plc
  • Aurobindo Pharma Limited
  • Apotex Inc.
  • Taro Pharmaceutical Industries Ltd
  • Stada Arzneimittel AG
  • Krka Pharmaceuticals
  • CordenPharma International
  • Evonik Industries AG
  • Biological E. Limited

11. Section

• References
• Research Methodology
• About us and Sales Contact